Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells

Molecular and Cellular Biology

Volumn 33, Issue 24, 2013, Pages 4824-4833

  Yan, Ling ^a   Womack, Bethany ^a   Wotton, David ^b   Guo, Yan ^a   Shyr, Yu ^a,c   Davé, Utpal ^a,c   Li, Chun ^a   Hiebert, Scott ^c   Brandt, Stephen ^a,c   Hamid, Rizwan ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; RNA; TG INTERACTING FACTOR 1 PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; TGIF PROTEIN, MOUSE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL AGING; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CFU COUNTING; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; IN VIVO CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; STEM CELL TRANSPLANTATION; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE KNOCKOUT TECHNIQUES; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84893095823     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01076-13     Document Type: Article

References (53)

1. Burglin TR. 1997. Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals. Nucleic Acids Res. 25:4173-4180.
2. Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D. 2006. TGIF inhibits retinoid signaling. Mol. Cell. Biol. 26:990-1001.
3. Seo SR, Lallemand F, Ferrand N, Pessah M, L'Hoste S, Camonis J, Atfi A. 2004. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 23:3780-3792.
4. Seo SR, Ferrand N, Faresse N, Prunier C, Abecassis L, Pessah M, Bourgeade MF, Atfi A. 2006. Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling. Mol. Cell 23:547-559.
5. Wotton D, Lo RS, Lee S, Massague J. 1999. A Smad transcriptional corepressor. Cell 97:29-39.
6. Wotton D, Lo RS, Swaby LA, Massague J. 1999. Multiple modes of repression by the Smad transcriptional corepressor TGIF. J. Biol. Chem. 274:37105-37110.
7. Wotton D, Massague J. 2001. Smad transcriptional corepressors in TGF beta family signaling. Curr. Top. Microbiol. Immunol. 254:145-164.
8. Gripp KW, Wotton D, Edwards MC, Roessler E, Ades L, Meinecke P, Richieri-Costa A, Zackai EH, Massague J, Muenke M, Elledge SJ. 2000. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat. Genet. 25:205-208.
9. Wallis DE, Muenke M. 1999. Molecular mechanisms of holoprosencephaly. Mol. Genet. Metab. 68:126-138.
10. Wallis D, Muenke M. 2000. Mutations in holoprosencephaly. Hum. Mutat. 16:99-108.
11. Ming JE, Muenke M. 2002. Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am. J. Hum. Genet. 71:1017-1032.
12. Powers SE, Taniguchi K, Yen W, Melhuish TA, Shen J, Walsh CA, Sutherland AE, Wotton D. 2010. Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. Development 137:249-259.
13. Taniguchi K, Anderson AE, Sutherland AE, Wotton D. 2012. Loss of Tgif function causes holoprosencephaly by disrupting the SHH signaling pathway. PLoS Genet. 8:e1002524. doi:10.1371/journal.pgen.1002524.
14. Langer JC, Henckaerts E, Orenstein J, Snoeck HW. 2004. Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J. Exp. Med. 199:5-14.
15. Yamazaki S, Iwama A, Takayanagi S, Eto K, Ema H, Nakauchi H. 2009. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 113:1250-1256.
16. Evans T. 2005. Regulation of hematopoiesis by retinoid signaling. Exp. Hematol. 33:1055-1061.
17. Hamid R, Brandt SJ. 2009. Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells. Mol. Oncol. 3:451-463.
18. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, Deanehan JK, Moore KA, Overton GC, Lemischka IR. 2000. The genetic program of hematopoietic stem cells. Science 288:1635-1640.
19. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. 2003. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260:404-413.
20. Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, Shaw CA, Goodell MA. 2004. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2:e301. doi:10.1371/journal.pbio.0020301.
21. Means-Powell JA, Kravtsov VD, Shyr Y, Levy SE, Greer JP, Koury MJ, Brandt SJ. 2003. Expression of homeobox gene TG-interaction factor is an independent predictor of survival in acute myelogenous leukemia, abstr 764, p 128a. Platform presentation, 45th Am. Soc. Hematol. Meet.
22. Harrison DE, Astle CM. 1997. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood. Blood 90:174-181.
23. Zon LI. 2008. Self-renewal and differentiation at Cell Stem Cell. Cell Stem Cell 2:510.
24. Rossi L, Lin KK, Boles NC, Yang L, King KY, Jeong M, Mayle A, Goodell MA. 2012. Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice. Cell Stem Cell 11:302-317.
25. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-1808.
26. Cheshier SH, Morrison SJ, Liao X, Weissman IL. 1999. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 96:3120-3125.
27. Pietras EM, Warr MR, Passegue E. 2011. Cell cycle regulation in hematopoietic stem cells. J. Cell Biol. 195:709-720.
28. Zon LI. 2008. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 453:306-313.
29. Li L, Bhatia R. 2011. Stem cell quiescence. Clin. Cancer Res. 17:4936-4941.
30. Bianco P. 2011. Bone and the hematopoietic niche: a tale of two stem cells. Blood 117:5281-5288.
31. Blank U, Karlsson G, Karlsson S. 2008. Signaling pathways governing stem-cell fate. Blood 111:492-503.
32. Bartholin L, Melhuish TA, Powers SE, Goddard-Leon S, Treilleux I, Sutherland AE, Wotton D. 2008. Maternal Tgif is required for vascularization of the embryonic placenta. Dev. Biol. 319:285-297.
33. Fischer MA, Moreno-Miralles I, Hunt A, Chyla BJ, Hiebert SW. 2012. Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. EMBO J. 31:1494-1505.
34. Harrison DE, Jordan CT, Zhong RK, Astle CM. 1993. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp. Hematol. 21:206-219.
35. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7:562-578.
36. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
37. Lemischka IR, Raulet DH, Mulligan RC. 1986. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917-927.
38. Zerlanko BJ, Bartholin L, Melhuish TA, Wotton D. 2012. Premature senescence and increased TGFbeta signaling in the absence of Tgif1. PLoS One 7:e35460. doi:10.1371/journal.pone.0035460.
39. Rodrigues NP, Janzen V, Forkert R, Dombkowski DM, Boyd AS, Orkin SH, Enver T, Vyas P, Scadden DT. 2005. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106:477-484.
40. Chan RJ, Li Y, Hass MN, Walter A, Voorhorst CS, Shelley WC, Yang Z, Orschell CM, Yoder MC. 2006. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal. Exp. Hematol. 34:1230-1239.
41. Wang J, Fernald AA, Anastasi J, Le Beau MM, Qian Z. 2010. Haploinsufficiency of Apc leads to ineffective hematopoiesis. Blood 115:3481-3488.
42. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18:2747-2763.
43. Brenet F, Kermani P, Spektor R, Rafii S, Scandura JM. 2013. TGFbeta restores hematopoietic homeostasis after myelosuppressive chemotherapy. J. Exp. Med. 210:623-639.
44. Ficara F, Murphy MJ, Lin M, Cleary ML. 2008. Pbx1 regulates selfrenewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell 2:484-496.
45. Chen Y, Hu Y, Zhang H, Peng C, Li S. 2009. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet. 41:783-792.
46. Kocabas F, Zheng J, Thet S, Copeland NG, Jenkins NA, Deberardinis RJ, Zhang C, Sadek HA. 2012. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 120:4963-4972.
47. Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q, Lund EA, Wu B, Kowal BJ, Kersey JH. 2009. A role for MEIS1 in MLL-fusion gene leukemia. Blood 113:1756-1758.
48. Sanyal M, Tung JW, Karsunky H, Zeng H, Selleri L, Weissman IL, Herzenberg LA, Cleary ML. 2007. B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood 109:4191-4199.
49. Rosales-Avina JA, Torres-Flores J, Aguilar-Lemarroy A, Gurrola-Diaz C, Hernandez-Flores G, Ortiz-Lazareno PC, Lerma-Diaz JM, de Celis R, Gonzalez-Ramella O, Barrera-Chaires E, Bravo-Cuellar A, Jave-Suarez LF. 2011. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance. J. Exp. Clin. Cancer Res. 30:112.
50. Kumar AR, Sarver AL, Wu B, Kersey JH. 2010. Meis1 maintains stemness signature in MLL-AF9 leukemia. Blood 115:3642-3643.
51. Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD. 2006. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 9:175-187.
52. Metzeler KH, Heilmeier B, Edmaier KE, Rawat VP, Dufour A, Dohner K, Feuring-Buske M, Braess J, Spiekermann K, Buchner T, Sauerland MC, Dohner H, Hiddemann W, Bohlander SK, Schlenk RF, Bullinger L, Buske C. 2012. High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Blood 120:2118-2126.
53. Means-Powell J, Martincic D, Brandt S, Hamid R. 2010. Genetic heterogeneity in Tg-Interacting Factor (TGIF) expression is a modifier of acute myeloid leukemia, abstr 523/T, p 127. Abstr. 60th Annu. Meet. Am. Soc. Hum. Genet., Washington, DC.